share_log

Moderna | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.20%)

SEC announcement ·  Apr 11 02:08
Summary by Futu AI
The Vanguard Group has filed an amended Schedule 13G/A with the Securities and Exchange Commission on April 10, 2024, indicating a change in their holdings of Moderna Inc. As of March 28, 2024, The Vanguard Group reported a 10.20% ownership stake in Moderna, with an aggregate amount of 39,036,765 shares beneficially owned. This includes both sole and shared voting and dispositive power over the shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of Moderna Inc.
The Vanguard Group has filed an amended Schedule 13G/A with the Securities and Exchange Commission on April 10, 2024, indicating a change in their holdings of Moderna Inc. As of March 28, 2024, The Vanguard Group reported a 10.20% ownership stake in Moderna, with an aggregate amount of 39,036,765 shares beneficially owned. This includes both sole and shared voting and dispositive power over the shares. The Vanguard Group, headquartered in Pennsylvania, is an investment adviser and reports that the securities were acquired in the ordinary course of business, not with the purpose of changing or influencing the control of Moderna Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.